YORK AGAINST CANCER

Registered charity 1130835 · accounts filings on the Charity Commission register

To raise funds to support cancer patients and advance the alleviation and cure of cancer.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£1.5m
Latest spending
£1.1m
Registered
2009
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that the charity reported a surplus of £323,567 for the year ended 31 December 2024, with total unrestricted undesignated reserves of £1,521,157. The trustees note that the level of free reserves is equivalent to 12 months of budgeted undesignated operating costs, which aligns with their stated policy. The charity holds total funds of £4,466,498, supported by significant investment assets valued at £2,980,638.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: 12 months of our operating costs (held: £1.5m)
“It is the charity’s policy to hold 12 months of our operating costs as the charity is largely reliant on donated and legacy income.”
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Accountancy services paid to HPH Chartered Accountants, a firm in which the Treasurer is a partner.
“During the year the Charitable Company paid £3,094 (2023 £3,182) to HPH Chartered Accountants for accountancy services and software costs, a firm in which the Charitable Company's Treasurer, Sarah Wearing, is a partner.” — page 40
“During 2024 Trustees and related parties donated £5,654 (2023 - £6,100) to the charity.” — page 40
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Donations from Trustees and related parties.
“During the year the Charitable Company paid £3,094 (2023 £3,182) to HPH Chartered Accountants for accountancy services and software costs, a firm in which the Charitable Company's Treasurer, Sarah Wearing, is a partner.” — page 40
“During 2024 Trustees and related parties donated £5,654 (2023 - £6,100) to the charity.” — page 40
Per its FY2024 accounts as filed with the Charity Commission.
Trading subsidiary: York Against Cancer Trading Company Limited
“The Charity owns the whole of the issued ordinary share capital of York Against Cancer Trading Company Limited, a company registered in England and Wales. The subsidiary is used for the raising of funds for the Charity through the sale of bought in goods through the Charity’s two shops.” — page 20
Per its FY2024 accounts as filed with the Charity Commission.

Accounts audited by Henton & Co LLP. Discloses 5 of 6 completeness components.

Public fundraising profile: JustGiving — York Against Cancer (matched by registered charity number).

Leadership, per the charity’s website

Listed on the charity’s own website when we last crawled it; roles may have changed. Pay-band disclosures above are anonymous statutory disclosures and are not attributed to any named individual.

Property (HM Land Registry)

5 registered titles in England and Wales held by the charity’s company or corporate body (1 freehold); recorded price paid £332k. All charity-held property. Contains HM Land Registry data © Crown copyright, OGL v3.0.

Public profiles (found on the charity’s own website): facebook · instagram

Structured financials (annual return, FY ending 31/12/2024)

Total income
£1.5m
Total spending
£1.1m
Cost of raising funds
£344k
Reserves (reported)
£1.1m
Employees
10

Reported reserves equal ~11.8 months of spending — in the top quarter for charities its size (median 4.8 months; benchmarks).

Per its annual return, cost of raising funds: 23.5% of total income — in the top quarter for charities its size (median 5.2%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: City Of York · North Yorkshire

Income and spending

Financial year endIncomeSpending
31/12/2024£1.5m£1.1m
31/12/2023£764k£1.1m
31/12/2022£1.5m£1.8m
31/12/2021£648k£538k
31/12/2020£390k£537k

Common questions

Is YORK AGAINST CANCER financially healthy?

Per its FY2024 accounts: The accounts state that the charity reported a surplus of £323,567 for the year ended 31 December 2024, with total unrestricted undesignated reserves of £1,521,157. The trustees note that the level of free reserves is equivalent to 12 months of budgeted undesignated operating costs, which aligns with their stated policy. The charity holds total funds of £4,466,498, supported by significant investment assets valued at £2,980,638. Its FY2024 accounts were audited by Henton & Co LLP.

Who funds YORK AGAINST CANCER?

Funders whose own accounts filings name YORK AGAINST CANCER as a grant recipient include THE PATRICIA AND DONALD SHEPHERD CHARITABLE TRUST, THE HISCOX FOUNDATION, THE SYLVIA AND COLIN SHEPHERD CHARITABLE TRUST.

Known funders

Grants to this charity found in funders’ own accounts filings.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with YORKSHIRE CANCER RESEARCH.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
YORK AGAINST CANCER£1.5m—0within—no doubt
YORKSHIRE CANCER RESEARCH FY2025£27.7m——unclear—no doubt
TOGETHER AGAINST CANCER FY2025£508k—0unclear—no doubt
YORK CARES FY2025£326k£17,9960unclear—no doubt
CANCER RELIEF UK FY2025£229kUnder £60,0000above—no doubt
YORK RI FY2025£564k—0unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.